Nalpac Issues Voluntary Nationwide Recall of DTF Sexual Chocolate Due to Presence of Undeclared Sildenafil and Tadalafil
Summary
Nalpac voluntarily recalls DTF Sexual Chocolate nationwide after FDA testing detected undeclared sildenafil and tadalafil, the active pharmaceutical ingredients in Viagra and Cialis. The recalled product (UPC 757817783069) was sold in adult retail stores and online through shopsexology.com and royalsins.com. Retailers must immediately remove the product from shelves, and consumers should stop using it and return or discard it, as the undeclared ingredients pose serious health risks, particularly for those taking nitrate medications.
What changed
Nalpac issued a nationwide voluntary recall for DTF Sexual Chocolate (UPC 757817783069) after discovering undeclared sildenafil and tadalafil, the active ingredients in FDA-approved erectile dysfunction medications. The product was distributed through adult retail stores and online platforms shopsexology.com and royalsins.com, packaged in cases of 20 retail units. Retailers must immediately cease selling the product and notify consumers to stop use, while consumers should return or discard any remaining inventory. The presence of these undeclared pharmaceutical ingredients poses significant health risks, particularly dangerous interactions with nitrates found in prescription medications such as nitroglycerin, potentially causing life-threatening hypotension. Consumers using nitrate medications who have consumed this product should contact their healthcare provider immediately.
What to do next
- Stop using DTF Sexual Chocolate immediately and do not consume any remaining product
- Return recalled product to place of purchase or discard it
- Contact your physician if you have experienced any adverse health effects from using this product
Archived snapshot
Apr 8, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
More Recalls, Market
Withdrawals, &
Safety Alerts
Summary
Company Announcement Date:
April 06, 2026
FDA Publish Date:
April 07, 2026
Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Undeclared Sildenafil and Tadalafil Company Name: Nalpac Brand Name: Brand Name(s) DTF Sexual Chocolate Product Description: Product Description Chocolate
Company Announcement
FOR IMMEDIATE RELEASE – Date – Ferndale, Michigan. Nalpac is voluntarily recalling DTF Sexual Chocolate it purchased and resold. The products have been found to contain sildenafil and tadalafil. Nalpac is not the manufacturer of this product.
Sildenafil and tadalafil are the active ingredients in the FDA-approved prescription drugs Viagra and Cialis, respectively, used to treat erectile dysfunction. FDA approval of Viagra and Cialis is restricted to use under the supervision of a licensed health care professional. These undeclared ingredients could interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels for those individuals who use prescriptions drugs which contain nitrates. Nalpac has not received any reports of adverse events related to this recall.
The recalled product is packaged in cases containing 20 retail units. The product can be identified by UPC 757817783069 on the product label. The product was available for purchase in adult retail stores and through shopsexology.com and royalsins.com. Please find the product label below:
Nalpac is not the Manufacturer of these products but is voluntarily recalling the product, notifying its customers by email and is arranging for return of all recalled products. Consumers and retailers that have the recalled product should stop using or selling products and return to the place of purchase or discard immediately.
Consumers with questions regarding this recall can contact Nalpac by telephone at 248-541-1140 or by email at sales@nalpac.com Monday to Friday from 8:00 am to 4:30 pm eastern. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report:
- Online: www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178 This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Company Contact Information
Consumers: 248-541-1140 sales@nalpac.com
Product Photos
Content current as of:
04/07/2026
Regulated Product(s)
- Food & Beverages
Follow FDA
Related changes
Get daily alerts for FDA Recalls & Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FDA Recalls & Safety Alerts publishes new changes.